-
Time Is Still The Enemy, Says Mom Who Moved Mountains For Her Epileptic Daughter & Still Advocates For Millions Of CBD Users
Tuesday, March 12, 2024 - 1:44pm | 1597If there's love that could move the Earth, it's that of a parent towards a child. And, as the Chinese proverb says, ‘To understand your parent's love, you must raise children yourself.' Today's story is about a mother who once moved mountains for her daughter and continues...
-
How One Cannabis Blunt Changed This Man's Life: From Monthly Seizures And Depression To A Holistic Lifestyle
Tuesday, March 5, 2024 - 2:39pm | 1363"Nature is the source of all true knowledge." Leonardo da Vinci (1452 – 1519) Did you know that some 50 million people around the world suffer from epilepsy? Estimates say that up to 70% of people living with this neurological disease could live seizure-free if properly diagnosed and...
-
Cannabis Research In India Tackles Cancer, Malta's Cannabis Clubs, Guernsey's Medical Marijuana
Friday, June 9, 2023 - 6:38am | 567India Moves Towards Medical Independence: Cannabis Research Project Targets Cancer and Epilepsy The Cannabis Research Project by the Council of Scientific and Industrial Research - Indian Institute of Integrative Medicine (CSIR-IIIM) in Jammu, the most populous district in the Indian...
-
Benefit Concert To Honor The Legacy Of Charlotte Figi
Monday, April 5, 2021 - 1:21pm | 376Charlotte Figi, a young girl from Colorado, who helped spread the word about the benefits of CBD in those suffering from rare forms of epilepsy, will never be forgotten. This week, on April 7th, a benefit concert in her honor will be held in her memory. Charlotte's Story Charlotte became famous...
-
'An Incredible Signal': 4 Experts Weigh In On Positive FDA Panel Vote For GW Pharma's Epidiolex
Thursday, April 19, 2018 - 4:37pm | 740Shares of GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) were halted Thursday, ahead of a Food and Drug Administration vote on the company's cannabis-derived drug Epidiolex. Trading resumed after the FDA advisory panel voted unanimously in favor of approving the medicine for the treatment of two...
-
Why GW Pharma's Epidiolex Results Could Shape The Future Of Cannabis-Based Therapeutics
Thursday, January 25, 2018 - 4:51pm | 1039Medical journal The Lancet published an article Wednesday that could mold the future of cannabis-derived therapeutics. The piece in question featured results from GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) and Greenwich Biosciences’ Phase 3 study of Epidiolex — an oral cannabidiol...